Allergy, living and learning: Diagnosis and treatment of allergic respiratory diseases in Europe

Journal of Investigational Allergology and Clinical Immunology

Volumn 22, Issue 3, 2012, Pages 168-179

  Chivato, Tomás ^a   Valovirta, E ^b,c   Dahl, R ^d   de Monchy, J ^e   Bloch Thomsen, A ^f,g   Palkonen, S ^h   Jacobsen, L ^i,j  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b Terveystalo Turku Allergy Clinic   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f ALK ABELLÓ   (Denmark)

^g NOVO NORDISK A S   (Denmark)

^h European Federation of Allergy and Airways Diseases Patients' Associations   (Belgium)

ⁱ GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^j ALC   (Denmark)

more..

Author keywords

Allergic rhinitis; Allergy diagnosis; Allergy medication; Allergy specific immunotherapy; Asthma; Pharmacological treatment

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; NOSE SPRAY;

ADL DISABILITY; ADOLESCENT; ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; DIAGNOSTIC TEST; EUROPE; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT SATISFACTION; QUALITY OF LIFE; RESPIRATORY TRACT ALLERGY; SELF REPORT; TABLET;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; ASTHMA; EUROPE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNOTHERAPY; LEARNING; MALE; MIDDLE AGED; PATIENT SATISFACTION; PERCEPTION; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS, ALLERGIC, SEASONAL; YOUNG ADULT;

EID: 84860850466     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Petersen KD, Kronborg C, Gyrd-Hansen D, Dahl R, Larsen JN, Løwenstein H. Quality of life in rhinoconjunctivitis assessed with generic and disease-specific questionnaires. Allergy. 2008;63:284-91.
2. Valovirta E, Myrseth SE, Palkonen S. The voice of the patients: allergic rhinitis is not a trivial disease. Curr Opin Allergy Clin Immunol. 2008;8:1-9.
3. Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol. 2007;120:381-7.
4. Vuurman EF, van Veggel LM, Uiterwijk MM, Leutner D, O'Hanlon JF. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy. 1993;71:121-6.
5. Petersen KD. Impact of allergy and asthma on quality of life and comparison with other diseases. Drugs Today (Barc). 2008;44(Suppl B):17-8.
6. Lamb CE, Ratner PH, Johnson CE, Ambegaonkar AJ, Joshi AV, Day D, Sampson N, Eng B. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin. 2006;22:1203-10.
7. de Monchy J, Andersen PS, Bergmann KC, Chivato T, Holm-Hansen A, Jarisch R, Mohácsi EF, Rak S, Slørdal S, Spicak V, Valovirta E, Dahl R. Living & learning with allergy: a European perception study on respiratory allergic disorders. Respir Med. 2004;98:404-12.
8. Dahl R, Andersen PS, Chivato T, Valovirta E, de Monchy J. National prevalence of respiratory allergic disorders. Respir Med. 2004;98:398-403.
9. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5 Suppl):S147-S334.
10. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D; World Health Organization; GA(2)LEN. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008;63(Suppl 86):8-160.
11. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, 2008. http://www.ginasthma. org.
12. van Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, Canonica GW, Durham SR, Fokkens WJ, Howarth PH, Lund V, Malling HJ, Mygind N, Passali D, Scadding GK, Wang DY. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy. 2000;55:116-34.
13. Simons FE. Advances in H1-antihistamines. N Engl J Med. 2004;351:2203-17.
14. Johnson DA, Hricik JG. The pharmacology of alpha-adrenergic decongestants. Pharmacotherapy. 1993;13:110S-5S.
15. DeWester J, Philpot EE, Westlund RE, Cook CK, Rickard KA. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy Asthma Proc. 2003;24:331-7.
16. Holm AF, Fokkens WJ, Godthelp T, Mulder PG, Vroom TM, Rijntjes E. A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study. Clin Otolaryngol. 1998;23:69-73.
17. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis. 1990;142(4):832-6.
18. Meltzer EO, Orgel HA, Bronsky EA, Furukawa CT, Grossman J, LaForce CF, Lemanske RF Jr, Paull BD, Pearlman DS, Ratner PH, et al. A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry and nasal cytology. J Allergy Clin Immunol. 1990;86:221-30.
19. Schenkel E. Features of mometasone furoate nasal spray and its utility in the management of allergic rhinitis. Expert Opin Pharmacother. 2003;4:1579-91.
20. Selner JC, Weber RW, Richmond GW, Stricker WE, Norton JD. Onset of action of aqueous beclomethasone dipropionate nasal spray in seasonal allergic rhinitis. Clin Ther 1995;17:1099-109.
21. Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med. 1995;151:969-74.
22. Abramson M, Puy R, Weiner J. Immunotherapy in asthma: an updated systematic review. Allergy. 1999;54:1022-41.
23. Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy. 2005;60:4-12.
24. Frew AJ, Powell RJ, Corrigan CJ. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006;117:319-25.
25. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomised controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006;117:802-9.
26. Dahl R, Kapp A, Colombo G, de Monchy JGR, Rak S, Emminger W, Rivas MF, Ribel M, Durham SR. Efficacy and safety of sublingual immunotherapy with grass allergen tablet for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006;118:434-40.
27. Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Riis B, Grønager PM, Durham SR. Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. J Allergy Clin Immunol. 2008;121:512-8.
28. Durham SR, Emminger W, Kapp A, Colombo G, de Monchy JGR, Rak S, Scadding GK, Andersen JS, Riis B, Dahl R. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol. 2010;125 (1):131-8.
29. Plaut M, Valentine MD. Clinical practice. Allergic rhinitis. N Engl J Med 2005;353:1934-44.
30. Bousquet J. Primum non nocere (Editorial). Prim Care Respir J. 2005;14:122-3.
31. Dykewicz MS, Fineman S, Nicklas R, Lee R, Blessing-Moore J, Li JT, Bernstein IL, Berger W, Spector S, Schuller D. Joint task force algorithm and annotations for diagnosis and management of rhinitis. Ann Allergy Asthma Immunol. 1998;81:469-73.